CL vs ITRM · P/E 34, rev $20.38B vs rev $390.0K
Colgate-Palmolive Company (CL) versus Iterum Therapeutics PLC (ITRM) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Iterum Therapeutics PLC (ITRM) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported ITRM revenue for 2025-09-30 was $390.0K. Net income was -$20.4M. ITRM currently screens at market cap $38.6M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. ITRM currently screens at market cap $38.6M.
Not investment advice. Open the CL and ITRM stock pages for the full models.
Not investment advice.